Closed
Source verified July 18, 2026
Operating Grant: COVID-19 Outpatient Therapeutic Study
Supports COVID-19 outpatient treatment research
Funding available
$ 10,000,000
Deadline
Closed
Location
Canada
Who can apply
Eligible candidates
Overview
Operating Grant: COVID-19 Outpatient Therapeutic Study supports rapid research on COVID-19 treatments for non-hospitalized patients in Canadian healthcare settings, with up to $10 million available for up to one year. Projects must include an adaptive platform trial, strong governance, pan-Canadian collaboration, patient and citizen engagement, and knowledge mobilization to generate evidence on effectiveness, cost-effectiveness, and outcomes.
Find open grants for your business
Explore open funding programs that match your business and project.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Maximum amount : 10,000,000 $
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Adaptive platform trial evaluating COVID-19 treatments for non-hospitalized patients in Canadian healthcare settings.
- Research on effectiveness, comparative clinical effectiveness, cost-effectiveness, practical challenges, and outcomes.
- Studies using well-structured designs and well-defined outcome measures.
- Evidence generation on diverse populations, including marginalized communities, First Nations, Inuit, Métis, Urban Indigenous Peoples, and people with disabilities.
Documents Needed
- An up to 250-word summary in PDF format describing relevant and recent experience in managing clinical trial groups or networks and the planned approach to engage member groups or networks across diverse areas to collaborate on the evaluation of COVID-19 treatments in non-hospital settings.
Official resources
How to apply
- Submit an EOI by email to support-soutien@cihr-irsc.gc.ca no later than 8:00 p.m. (ET) on May 5, 2022 to confirm your intent to participate in the call.
- Use the subject line COVID-19 Outpatient Therapeutic Study - EOI.
- Attach an up to 250-word summary in PDF format describing relevant and recent experience and the planned approach to collaborate across groups and networks.
Processing and Agreement
- Email submission confirms agreement to respect all relevant agency policies, including the Tri-Agency Framework: Responsible Conduct of Research.
- In cases of serious breach, the agency may publicly disclose information relevant to the breach that is in the public interest, including your name, the institution where you were employed at the time, your current institution, and the recourse imposed.
- Email submission also consents to CIHR coordinating a call with other applicants to explore collaborations and sharing the submitted summary with other potential applicants.
Additional information
- The Public Health Agency of Canada will provide relevant treatments.
Contacts
Frequently Asked Questions about the Operating Grant: COVID-19 Outpatient Therapeutic Study Program
What is the Operating Grant: COVID-19 Outpatient Therapeutic Study?
Operating Grant: COVID-19 Outpatient Therapeutic Study supports rapid research on COVID-19 treatments for non-hospitalized patients in Canadian healthcare settings, with up to $10 million available for up to one year. Projects must include an adaptive platform trial, strong governance, pan-Canadian collaboration, patient and citizen engagement, and knowledge mobilization to generate evidence on effectiveness, cost-effectiveness, and outcomes.
How much funding can be received?
Operating Grant: COVID-19 Outpatient Therapeutic Study Funds up to $10,000,000 of admissible expenses.
What expenses are eligible under Operating Grant: COVID-19 Outpatient Therapeutic Study?
Adaptive platform trial evaluating COVID-19 treatments for non-hospitalized patients in Canadian healthcare settings.
Research on effectiveness, comparative clinical effectiveness, cost-effectiveness, practical challenges, and outcomes.
Studies using well-structured designs and well-defined outcome measures.
Evidence generation on diverse populations, including marginalized communities, First Nations, Inuit, Métis, Urban Indigenous Peoples, and people with disabilities.
Who can I contact for more information about the Operating Grant: COVID-19 Outpatient Therapeutic Study?
You can contact Canadian Institutes of Health Research (CIHR) by email at support-soutien@cihr-irsc.gc.ca or by phone at 613-954-1968.
Where is the Operating Grant: COVID-19 Outpatient Therapeutic Study available?
The Operating Grant: COVID-19 Outpatient Therapeutic Study program is available across Canada.
Is the Operating Grant: COVID-19 Outpatient Therapeutic Study a grant, loan, or tax credit?
Operating Grant: COVID-19 Outpatient Therapeutic Study is a Grant and Funding
Who are the financial supporters of the Operating Grant: COVID-19 Outpatient Therapeutic Study?
Operating Grant: COVID-19 Outpatient Therapeutic Study is funded by Canadian Institutes of Health Research (CIHR)